K. Altundag Et Al. , "Re: Cetuximab therapy and symptomatic hypomagnesemia," JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE , vol.97, no.23, pp.1791-1792, 2005
Altundag, K. Et Al. 2005. Re: Cetuximab therapy and symptomatic hypomagnesemia. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE , vol.97, no.23 , 1791-1792.
Altundag, K., Altundag, O., Baptista, M., Turen, S., & Atik, M., (2005). Re: Cetuximab therapy and symptomatic hypomagnesemia. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE , vol.97, no.23, 1791-1792.
Altundag, K Et Al. "Re: Cetuximab therapy and symptomatic hypomagnesemia," JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE , vol.97, no.23, 1791-1792, 2005
Altundag, K Et Al. "Re: Cetuximab therapy and symptomatic hypomagnesemia." JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE , vol.97, no.23, pp.1791-1792, 2005
Altundag, K. Et Al. (2005) . "Re: Cetuximab therapy and symptomatic hypomagnesemia." JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE , vol.97, no.23, pp.1791-1792.
@article{article, author={K Altundag Et Al. }, title={Re: Cetuximab therapy and symptomatic hypomagnesemia}, journal={JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE}, year=2005, pages={1791-1792} }